Innovation Pharmaceuticals Inc (IPIX)

[george h]

POPULAR SCIENCE ARTICLE
http://www.popsci.com/article/science/age-antibiotics-over

I emailed to the author, Brooke Borel the following:
Brooke,
Thanks for the article on antibiotics in Popular Science.
Clearly we have used and overused our current arsenal to the point of exhaustion and new thinking must come into play if we are to continue to be safe from the deadly scourge of evolving bacteria. Let me bring to your attention a drug in trials now, Brilacidin, a new class of drug called a defensin-mimetic.
I own stock in the company, Cellceutix, CTIX, that has Brilacidin in trials, and is about to announce results in the next several weeks or months. Here is a link to the company webpage that can explain it better than I. http://cellceutix.com/brilacidin/#sthash.seNp1mfS.dpbs

Cellceutix has another drug, Kevetrin, for cancer, in trials at Harvard's Dana-Farber and Beth Israel Cancer Centers, another potential blockbuster.

In my opinion, CTIX is drastically undervalued.

Thanks again,
George Harvey